Published on
Doxycycline use was associated with an increased risk for pregnancy loss in a retrospective cohort study involving 224,870 pregnancies, published in the Annals of Internal Medicine. Researchers examined the association between first-trimester doxycycline exposure and pregnancy loss, including spontaneous abortion and stillbirth, within commercial insurance and Medicaid claims, comparing doxycycline with other antibiotics prescribed for respiratory tract infections (RTIs) or acne. Among patients with RTIs (218,234 pregnancies), doxycycline was associated with significantly greater pregnancy loss risk than amoxicillin (adjusted risk ratio [aRR], 1.54 in commercial insurance data and 1.40 in Medicaid data). Similar findings were documented when doxycycline was compared with macrolides (aRR, 1.39 and 1.36, respectively). For acne (6,636 pregnancies), doxycycline was associated with increased pregnancy loss risk compared with topical clindamycin in commercial insurance data (aRR, 1.49), but not Medicaid data (aRR, 1.03).
Careful consideration: Doxycycline is generally not recommended during pregnancy, but it is commonly used by women of childbearing age. The authors say the findings support careful consideration of doxycycline’s risks and benefits when prescribing to reproductive-aged women, including those with potentially unrecognized pregnancies.
